+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Microbiome Global Market Report 2020-30: Covid 19 Impact and Recovery

  • ID: 5018968
  • Report
  • April 2020
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 4D Pharma
  • Clinical Microbiomics AS
  • Ferring Pharmaceuticals
  • Microbiome Insights Inc.
  • Pharma PLC
  • Second Genome
  • MORE
Microbiome Market Global Report 2020: Covid 19 Impact and Recovery from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global microbiome market as it emerges from the Covid 19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 20+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:

Where is the largest and fastest growing market for the microbiome? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Microbiome market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider microbiome market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The microbiome market section of the report gives context. It compares the microbiome market with other segments of the microbiome market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, microbiome indicators comparison.
Scope

Markets Covered: 1) By Type: Shotgun; Targeted Gene; RNA; Whole-genome; Others; 2) By Application: Personalized medicines; Therapeutics; Genetic screening; Drug discovery; Biomarker discovery; Others

Companies Mentioned: Enterome Bioscience; Vedanta Biosciences Inc.; Osel Inc.; Synlogic Inc.; Second Genome

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA and Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 4D Pharma
  • Clinical Microbiomics AS
  • Ferring Pharmaceuticals
  • Microbiome Insights Inc.
  • Pharma PLC
  • Second Genome
  • MORE
1. Executive Summary

2. Microbiome Market Characteristics

3. Microbiome Market Size And Growth
3.1. Global Microbiome Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Microbiome Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Microbiome Market Segmentation
4.1. Global Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Shotgun
  • Targeted Gene
  • RNA
  • Whole-genome
  • Others
4.2. Global Microbiome Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Personalized medicines
  • Therapeutics
  • Genetic screening
  • Drug discovery
  • Biomarker discovery
  • Others
5. Microbiome Market Regional And Country Analysis
5.1. Global Microbiome Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Microbiome Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Microbiome Market
6.1. Asia-Pacific Microbiome Market Overview
6.2. Asia-Pacific Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Microbiome Market
7.1. China Microbiome Market Overview
7.2. China Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Microbiome Market
8.1. India Microbiome Market Overview
8.2. India Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Microbiome Market
9.1. Japan Microbiome Market Overview
9.2. Japan Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Microbiome Market
10.1. Australia Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Microbiome Market
11.1. Indonesia Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Microbiome Market
12.1. South Korea Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Microbiome Market
13.1. Western Europe Microbiome Market Overview
13.2. Western Europe Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Microbiome Market
14.1. UK Microbiome Market Overview
14.2. UK Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Microbiome Market
15.1. Germany Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Microbiome Market
16.1. France Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Microbiome Market
17.1. Eastern Europe Microbiome Market Overview
17.2. Eastern Europe Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Microbiome Market
18.1. Russia Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Microbiome Market
19.1. North America Microbiome Market Overview
19.2. North America Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Microbiome Market
20.1. USA Microbiome Market Overview
20.2. USA Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Microbiome Market
21.1. South America Microbiome Market Overview
21.2. South America Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Microbiome Market
22.1. Brazil Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Microbiome Market
23.1. Middle East Microbiome Market Overview
23.2. Middle East Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Microbiome Market
24.1. Africa Microbiome Market Overview
24.2. Africa Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Microbiome Market Competitive Landscape And Company Profiles
25.1. Microbiome Market Competitive Landscape
25.2. Microbiome Market Company Profiles
25.2.1. Enterome Bioscience
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Vedanta Biosciences Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Osel Inc.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Synlogic Inc.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Second Genome
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Microbiome Market

27. Microbiome Market Trends And Strategies

28. Microbiome Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 4D Pharma
  • Clinical Microbiomics AS
  • Ferring Pharmaceuticals
  • Microbiome Insights Inc.
  • Pharma PLC
  • Second Genome
  • MORE
Major players in the microbiome market are Enterome Bioscience, Vedanta Biosciences Inc., Osel Inc., Synlogic Inc., Second Genome, Seres Therapeutics, Synthetic Biologics Inc., uBiome, Inc., Metabiomics Corporate, Rebiotix Inc.

The global microbiome market is expected to decline from $0.34 billion in 2019 to $0.27 billion in 2020 at a compound annual growth rate (CAGR) of -20%. The decline is mainly due to the focus on Covid-19 outbreak and its treatment across the globe, resulting in patients of other illnesses delaying their episodes of care. The market is then expected to recover and reach $0.58 billion in 2023 at a CAGR of 14%.

The microbiome market consists of sales of bioactive molecules and related products which are used as immunotherapeutic agents in pharmaceuticals industry. The microbiome market is primarily engaged in the development and sales of these bioactive products which are used as immunotherapy for a wide variety of conditions such as infectious diseases, endocrine & metabolic disorders, inflammatory conditions, cancer, irritable bowel syndrome, neurological disorders, hematological disorders and cardiovascular disease as well.

North America was the largest region in the microbiome market in 2019. The microbiome market in Asia Pacific is forecasted to register the highest CAGR during 2019-2023.

Stringent government regulations are expected to limit the growth of the microbiome market. Regulations or restrictions by the government bodies to use human microbiome as a therapy or a diagnostic tool can be challenging for the pharmaceutical companies engaged in microbiome production. For example, in 2013, FDA released a guidance stating that fecal microbiota transplantation (FMT) procedures are not subject to FDA enforcement which became challenging for the newly emerged companies involved in microbiome development.

In January 2020, Psomagen-Macrogen Consortium acquired uBiome for a deal amount of $7.05 Million. The deal comprises of patent portfolio of 246 patents (60 registered US patents and 186 applications), nearly 300,000 sample data and laboratory equipment. Psomagen has become a key player in the microbiome sector with this acquisition.

A number of NGS (Next Generation Sequencing) programs and innovative approaches are being developed in the field of human microbiome. Sequencing of DNA present in a sample along with that of the bacteria which have been killed by the prophylactic treatment of the antibiotics is possible with the NGS technique. In 2019, Baseclear has increased its sequencing capacity by implementing Illumina NovaSeq 6000 platform which has an output of 3.0 Gb data per run. Technological advancements such as software programs allow easy analyzing of the metagenomic datasets related to the genes of the microbiota along with user-friendliness, ease of access and with ability to provide graphical representation for easy and quick understanding of the analyzed data. Specialized software programs available for analyzing the metagenomic data are FastQC, Fastx-Toolkit, PRINSEQ, and many others. Thus, technological advancements and innovative approaches aid in growth of the human microbiome market.

The increased number of lifestyle diseases such as diabetes, cancer, depression and many others in the historical period has positively affected the microbiome market. Lifestyle changes influences the micro flora internally at every stage of life leading to lifestyle diseases and thus altering the microbiome can help in minimizing these lifestyle diseases. Worldwide from 1975 the obesity population has nearly tripled and now 30% of the population is obese. In recent studies, Fecal Microbiome Transplantation has shown beneficial results in treating patients with obesity and also diabetes. Thus, increasing lifestyle changes which lead to lifestyle diseases help drive the growth of this market.
Note: Product cover images may vary from those shown
5 of 5
  • Enterome Bioscience
  • Vedanta Biosciences Inc.
  • Osel Inc.
  • Synlogic Inc.
  • Second Genome
  • Seres Therapeutics
  • Synthetic Biologics Inc.
  • uBiome, Inc.
  • Metabiomics Corporate
  • Rebiotix Inc
  • BiomX
  • Microbiome Therapeutics LLC
  • Yakult Honsha Co. Ltd
  • DuPont
  • 4D Pharma
  • BaseClear BV
  • ViThera Pharmaceuticals
  • Pharma PLC
  • Ferring Pharmaceuticals
  • Evelo Biosciences
  • LNC Therapeutics
  • E.I. du Pont de Nemours and Company
  • Clinical Microbiomics AS
  • Locus Biosciences
  • Microbiome Insights Inc.
  • MR DNA
  • PureTech Health
  • Zymo Research Corp.
  • OptiBiotix Health Plc
  • Ritter Pharmaceuticals
  • Assembly Bioscience Inc.
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll